Faslodex

positive negative up down good bad mixed

Biotech

Pfizer, Arvinas' PROTAC posts mixed results in first ph. 3 test

Vepdegestrant was unable to show an improvement in PFS in the intent-to-treat population.

James Waldron Mar 11, 2025 10:06am

Eli Lilly coffee ESMO 2023

Lilly wants to prove oncologist 'lore' with breast cancer med

Oct 22, 2023 3:00am